Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Yu Y et al. Homosecoiridoids from the flower buds of Lonicera japonica. 2011 J. Nat. Prod. pmid:21942812
Ajiro Y et al. Platelet-activating factor stimulates sodium-hydrogen exchange in ventricular myocytes. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21949111
Ma J et al. ATP: a mediator for HCl-induced TRPV1 activation in esophageal mucosa. 2011 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:21960521
Bragado MJ et al. Platelet-activating factor in Iberian pig spermatozoa: receptor expression and role as enhancer of the calcium-induced acrosome reaction. 2011 Reprod. Domest. Anim. pmid:22023717
Rastogi P et al. Urothelial cell platelet-activating factor production mediated by calcium-independent phospholipase A2γ. 2011 Urology pmid:21094990
Uriarte SM et al. Granule exocytosis contributes to priming and activation of the human neutrophil respiratory burst. 2011 J. Immunol. pmid:21642540
Frelinger AL et al. Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44. 2011 Thromb. Haemost. pmid:21713327
Byrne SN et al. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. 2011 Am. J. Pathol. pmid:21703403
Semini G et al. Impact of alkylphospholipids on the gene expression profile of HaCaT cells. 2011 Pharmacogenet. Genomics pmid:21681147
Khan BQ and Kemp SF Pathophysiology of anaphylaxis. 2011 Curr Opin Allergy Clin Immunol pmid:21659865
Lacy P et al. Agonist activation of f-actin-mediated eosinophil shape change and mediator release is dependent on Rac2. 2011 Int. Arch. Allergy Immunol. pmid:21576984
Mushtaq N et al. Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. 2011 J. Allergy Clin. Immunol. pmid:21247619
Singh TP et al. Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. 2011 Am. J. Pathol. pmid:21281802
Metz M and Maurer M Rupatadine for the treatment of allergic rhinitis and urticaria. 2011 Expert Rev Clin Immunol pmid:21162645
Cureton EL et al. Endothelin-1 attenuates increases in hydraulic conductivity due to platelet-activating factor via prostacyclin release. 2011 J. Appl. Physiol. pmid:21183623
Liu J et al. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase. 2011 Circ. Res. pmid:21183738
Ha SW and Lee CS Differential effect of platelet activating factor on 1-methyl-4-phenylpyridinium-induced cell death through regulation of apoptosis-related protein activation. 2010 May-Jun Neurochem. Int. pmid:20304020
Michelotto PV et al. Platelet-activating factor and evidence of oxidative stress in the bronchoalveolar fluid of Thoroughbred colts during race training. 2010 Mar-Apr J. Vet. Intern. Med. pmid:20102491
Ploppa A et al. Local anesthetic effects on human neutrophil priming and activation. 2010 Jan-Feb Reg Anesth Pain Med pmid:20048657
Ciprandi G and Cirillo I Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study. 2010 Apr-Jun J. Biol. Regul. Homeost. Agents pmid:20487631
Kordan W et al. Effect of platelet activating factor (PAF) supplementation in semen extender on viability and ATP content of cryopreserved canine spermatozoa. 2010 Pol J Vet Sci pmid:21370733
Garcia CC et al. Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. 2010 PLoS Pathog. pmid:21079759
de Souza Carmo EV et al. Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages. 2010 PLoS ONE pmid:21082032
Nandy D et al. Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes. 2010 J. Cell. Mol. Med. pmid:19754670
Borthakur A et al. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. 2010 Inflamm. Bowel Dis. pmid:19714753
Fité R and Borja J Rupatadine and heart rhythm disturbances. 2010 Clin. Pharmacol. Ther. pmid:19727070
Donado E et al. No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. 2010 Br J Clin Pharmacol pmid:20406224
Saad MM et al. Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils. 2010 Can J Anaesth pmid:19882198
Chen H et al. Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. 2010 Clin Oral Investig pmid:19826843
Sreevidya CS et al. Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair. 2010 J. Invest. Dermatol. pmid:19829299
Lautenschläger I et al. A model of the isolated perfused rat small intestine. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19910525
Yang Y et al. Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase. 2010 Eur. Respir. J. pmid:19926744
Cureton EL et al. Endothelin 1 and prostacyclin attenuate increases in hydraulic permeability caused by platelet-activating factor in rats. 2010 Shock pmid:19940814
Coppo R et al. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. 2010 Kidney Int. pmid:20016469
Xu Z et al. Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor. 2010 Mol. Ther. pmid:19953082
Ma J et al. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19959817
Wang L et al. Three new compounds from Morus nigra L. 2010 J Asian Nat Prod Res pmid:20552479
Lu J et al. Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. 2010 Pediatr. Res. pmid:20531249
Kim DD et al. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo. 2010 Microcirculation pmid:20163539
Yost CC et al. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. 2010 Biochimie pmid:20167241
Sharif NA and Wiernas TK Platelet-activating factor-induced intracellular signaling and release of cytokines and prostaglandin E2 in immortalized human corneal epithelial cells. 2010 J Ocul Pharmacol Ther pmid:20187806
Metz M et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. 2010 Ann. Allergy Asthma Immunol. pmid:20143651
Xiping Z et al. Effects of dexamethasone and Salvia miltiorrhizae on the small intestine and immune organs of rats with severe acute pancreatitis. 2010 Inflammation pmid:20127399
Incorvaia C et al. Anaphylaxis: an update on its understanding and management. 2010 Recent Pat Inflamm Allergy Drug Discov pmid:20100165
Moriguchi S et al. Platelet-activating factor-induced synaptic facilitation is associated with increased calcium/calmodulin-dependent protein kinase II, protein kinase C and extracellular signal-regulated kinase activities in the rat hippocampal CA1 region. 2010 Neuroscience pmid:20074623
Zhou X and He P Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS activity and microvessel permeability in rat venules. 2010 Cardiovasc. Res. pmid:20080986
Grassi G et al. Exogenous platelet-activating factor improves the motility of human spermatozoa evaluated with C.A.S.A.: optimal concentration and incubation time. 2010 J. Endocrinol. Invest. pmid:20220291
Binder U et al. The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulans. 2010 Mol. Microbiol. pmid:19889092
Shindou H [Discovery and characterization of novel lysophospholipid acyltransferases]. 2010 Seikagaku pmid:21348263
Peng SY et al. [Effect of ginkgolide B on the production of NO, IL-6 and RANTES from astrocytes]. 2010 Yao Xue Xue Bao pmid:21351565